Melanoma: PharmaVie rolls out HUVY in pharmacies for AI-assisted early detection

Melanoma: PharmaVie rolls out HUVY in pharmacies for AI-assisted early detection

November 2025

Partnership

Artificial Intelligence

Huvy device

HUVY is a dermatological assessment service deployed in community pharmacies, enabling the analysis of a pigmented lesion in under 15 seconds using an application paired with a dedicated dermatoscope. The artificial intelligence, trained on over 100,000 medical images, delivers a three-tier risk score (reassuring, equivocal, alert) in under 12 seconds to provide immediate guidance on appropriate triage and management.

The reported clinical performance is based on a sensitivity of 96% and a specificity of 72%. The solution is CE Class IIb certified, compliant with the MDR, hosted in an HDS-certified environment, and adheres to GDPR regulations. It does not establish a diagnosis, but rather provides a risk index designed to guide patient referral.

View all articles